Blog

Co-processed Pharmaceutical Solids – An Approach to Screening by Steve Byrn

2024-03-12T17:25:07+00:00

Co-processed pharmaceutical solids are of considerable interest because of the improvements co-processing can make in a number of solid state properties and pharmaceutical processes. Our first blog on this topic provided a general introduction Read more

Co-processed Pharmaceutical Solids – An Approach to Screening by Steve Byrn2024-03-12T17:25:07+00:00

Co-processed Pharmaceutical Solids – A General Introduction by Steve Byrn

2024-01-23T13:25:47+00:00

Co-processed pharmaceutical solids are rising to the forefront as an important concept in pharmaceutical development. This general introduction is the first in a planned series of blogs delving into this exciting area. Schenck and Read more

Co-processed Pharmaceutical Solids – A General Introduction by Steve Byrn2024-01-23T13:25:47+00:00

Identification of unknown crystals in a Vicks® DayQuil Severe LiquiCap

2022-07-27T15:22:56+00:00

Crystals were observed growing within a DayQuil Liquicap. This blog post describes the approach taken to isolate and identify the unknown crystals. Vicks® DayQuil™ Severe Cold & Flu provides an over the counter non-drowsy, Read more

Identification of unknown crystals in a Vicks® DayQuil Severe LiquiCap2022-07-27T15:22:56+00:00

Increasing the Effectiveness of Slurry Experiments to Confirm the Relative Stability of Polymorphs

2022-05-03T20:03:00+00:00

Thermodynamic stability and form selection. Form selection of active pharmaceutical ingredients is regarded as an essential part of drug development. The goal of form selection is to identify the most suitable solid form for Read more

Increasing the Effectiveness of Slurry Experiments to Confirm the Relative Stability of Polymorphs2022-05-03T20:03:00+00:00

Determining the Transition Temperature of Enantiotropic Polymorphs with Slow Transformation Kinetics

2022-04-11T15:46:52+00:00

Select the polymorph with attributes fit for development. It is well established that polymorphism is common in pharmaceutical active ingredients.1 Bernstein and others present statistics that, when they are appropriately screened up to three Read more

Determining the Transition Temperature of Enantiotropic Polymorphs with Slow Transformation Kinetics2022-04-11T15:46:52+00:00
Go to Top